Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > CNTB Connect Biopharma > Detailed Quotes

CNTB Connect Biopharma

Watchlist
1.150
-0.070-5.74%
Close  02/03 16:00 ET
1.130
-0.020-1.75%
Post Mkt Price 02/03 17:01 ET
High
1.210
Open
1.170
Turnover
37.73K
Low
1.135
Pre Close
1.220
Volume
32.05K
Market Cap
63.27M
P/E(TTM)
Loss
52wk High
5.100
Shares
55.02M
P/E(Static)
Loss
52wk Low
0.557
Float Cap
21.12M
Bid/Ask %
-52.38%
Historical High
29.274
Shs Float
18.36M
Volume Ratio
0.66
Historical Low
0.557
Dividend TTM
--
Div Yield TTM
--
P/B
0.30
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.18%
Amplitude
6.15%
Avg Price
1.177
Lot Size
1
Float Cap
21.12M
Bid/Ask %
-52.38%
Historical High
29.274
Shs Float
18.36M
Volume Ratio
0.66
Historical Low
0.557
Dividend TTM
--
P/B
0.30
Dividend LFY
--
Turnover Ratio
0.18%
Amplitude
6.15%
Avg Price
1.177
Lot Size
1
Price Forecast

News

Comment

Sign in to post a comment

No comment yet

Company Overview More
Connect Biopharma Holdings Ltd. engages in the development of therapies for the treatment of T cell-driven inflammatory diseases. Its lead product candidate, CBP-201, is an antibody designed to target interleukin-4 receptor alpha, or IL-4Ra, which is a validated target for the treatment of inflammatory diseases such as atopic dermatitis and asthma. The company was founded by Zheng Wei and Wu Bin Pan on November 23, 2015 and is headquartered in Taicang, China.
CEO: Dr. Zheng Wei, PhD
Market: NASDAQ
Listing Date: 03/19/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist